Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.890,91
0,00%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avadel Pharmaceuticals PLC (AVDL) Avadel Pharmaceuticals PLC (AVDL) Notizie

Avadel Pharmaceuticals PLC

AVDL
18,82
0,52 (2,84%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202414:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
01/4/202414:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
05/3/202414:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
04/3/202421:51EDGAR2Form 8-K - Current report
04/3/202421:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04/3/202412:35EDGAR2Form 8-K - Current report
04/3/202412:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/3/202412:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202414:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14/2/202413:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
16/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:20EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
29/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202320:54EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202313:09EDGAR2Form 8-K - Current report
08/11/202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
07/11/202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30/10/202313:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/10/202314:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05/10/202314:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
02/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
15/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202321:50EDGAR2Form 144 - Report of proposed sale of securities
11/8/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:37EDGAR2Form 8-K - Current report
09/8/202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
03/8/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:15EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
03/8/202313:30EDGAR2Form 8-K - Current report
02/8/202314:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/7/202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
Apertura: 18,63 Min: 17,9137 Max: 19,09
Chiusura: 18,30

La tua Cronologia

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network